Pramipexole dihydrochloride hydrate

SKU: orb1300317

Description

Pramipexole dihydrochloride hydrate, a non-ergot dopamine agonist, is the hydrochloride salt form of the benzothiazole derivative pramipexole. It selectively activates D2 and D3 dopamine receptors in brain regions like the striatum. This compound is widely used in in vitro and in vivo research for studying Parkinson's disease, restless legs syndrome, and dopaminergic signaling pathways.

Research Area

Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 191217-81-9
• MW: 302.26
• Purity: 99.55% (May vary between batches)
• Formula: C₁₀H₁₇N₃S·2HCl·H₂O
• SMILES: NC1=NC2=C(S1)C[C@H](CC2)NCCC.Cl.O.Cl
• Target: Dopamine Receptor
• Solubility: DMSO:3.46 mg/mL (11.45 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (3.31 mM);H2O:55 mg/mL (181.96 mM);Ethanol:< 1 mg/mL (insoluble or slightly soluble)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Parkinson's, Mirapex, middle, neuroprotection, neurological, occlusion, inhibit, Inhibitor, legs, D3, D2S, D2L, D4, disease, Dopamine Receptor, Dopamine, DopamineReceptor, cerebral, artery, syndrome, transient, RLS, restless, Pramipexole dihydrochloride Hydrate, Pramipexole dihydrochloride hydrate, Pramipexole 2HCl, Pramipexole 2HCl Monohydrate, Pramipexole dihydrochloride, tMCAO, recovery

Quick Database Links

Gene Symbol

Dopamine Receptor